NeoGenomics
NEO
$18.17
Share price
-1.73%
Change (1 day)
62.09%
Change (1 year)
NeoGenomics (NEO) - Net assets
Net assets on the balance sheet as of September 2023 : $0.94 B
According to NeoGenomics
's latest financial reports the company has $0.94 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
NeoGenomics - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $0.99 B | -9.95% |
| 2021-12-31 | $1.10 B | 59.63% |
| 2020-12-31 | $0.69 B | 36.83% |
| 2019-12-31 | $0.50 B | 58.35% |
| 2018-12-31 | $0.32 B | 55.91% |
| 2017-12-31 | $0.20 B | 10.15% |
| 2016-12-31 | $0.18 B | -21.64% |
| 2015-12-31 | $0.23 B | 294.19% |
| 2014-12-31 | $60.4 M | 178.22% |
| 2013-12-31 | $21.71 M | 135.58% |
| 2012-12-31 | $9.21 M | 56.28% |
| 2011-12-31 | $5.89 M | 88.1% |
| 2010-12-31 | $3.13 M | -44.45% |
| 2009-12-31 | $5.64 M | 275.94% |
| 2008-12-31 | $1.5 M | -35.36% |
| 2007-12-31 | $2.32 M | 4159.67% |
| 2006-12-31 | $0.05 M | -105.48% |
| 2005-12-31 | $-1 M | 133.2% |
| 2004-12-31 | $-0.43 M | 16% |
| 2003-12-31 | $-0.37 M | -1675.51% |
| 2002-12-31 | $0.02 M | -122.26% |
| 2001-12-31 | $-0.11 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Quest Diagnostics
DGX | $6.53 B | 590.18% | 🇺🇸 USA |
 LabCorp LH | $7.89 B | 733.04% | 🇺🇸 USA |
 RadNet RDNT | $0.76 B | -19.68% | 🇺🇸 USA |
 Psychemedics PMD | $9.12 M | -99.04% | 🇺🇸 USA |
 Enzo Biochem ENZ | $78.46 M | -91.72% | 🇺🇸 USA |